AI methods for Automated Identification of Regions of Inflammation from ⁹⁹ᵐTc-Maraciclatide Imaging Presented at the World Molecular Imaging Congress 2023
- September 9, 2023
London, UK, 9 September 2023, Serac Healthcare Limited (“Serac Healthcare” or “the Company”), a clinical radiopharmaceutical company developing innovative molecular imaging technologies, announces that a poster titled “Automatic segmentation of regions of inflammation using deep neural networks for ⁹⁹ᵐTc-Maraciclatide gamma camera imaging of rheumatoid arthritis” is being presented at the World Molecular Imaging Society meeting taking place from 5-9 September in Prague, Czech Republic.
